Posted on 9/8/20
Is Vertex Pharmaceuticals Stock a Buy?
A tumultuous 2020 has revealed the strengths and weaknesses of companies across the stock market spectrum. While many businesses have struggled to adjust to pandemic highs . . .
Posted on 7/23/20
Is Now a Good Time to Buy Pfizer Stock?
Investors were in a frenzy Monday morning after Pfizer (NYSE:PFE) announced early positive results from a potential coronavirus vaccine it is studying in partnership with BioNTech . . .
Posted on 7/20/20
Is Novavax Stock a Buy?
Novavax (NASDAQ:NVAX) has been dominating recent headlines. On July 7, the company announced that it had secured $1.6 billion from the White House's Operation Warp Speed . . .
Posted on 7/9/20
Regeneron Lands a $450 Million "Warp Speed" Contract for Its Prospective COVID-19 Treatment
Regeneron Pharmaceuticals (NASDAQ:REGN) announced Tuesday that it had received a $450 million Operation Warp Speed contract for the development and production of REGN-COV2, a COVID-19 treatment . . .
Posted on 6/22/20
Better Buy: Novartis vs. Teva Pharmaceutical
Novartis (NYSE:NVS) and Teva Pharmaceutical (NYSE:TEVA) are two very well-known names in the big pharma space. Shares for both companies have recovered well since their lows . . .
Posted on 6/22/20
Could Bristol Myers Squibb Be a Millionaire-Maker Stock?
Bristol Myers Squibb (NYSE:BMY) has long been an investor favorite for a few reasons. In December, the company increased its dividend for 2020 by 9.8%, which . . .
Posted on 6/15/20
Should Teladoc Be Worried About Zocdoc's New Telehealth Service?
The demand for virtual health services has boomed. Roughly 76% of hospitals across the nation utilize video and other technology to connect healthcare providers with their . . .
Posted on 6/5/20
Better Buy: Bristol Myers Squibb vs. Gilead Sciences
There are few names more well-known in the biopharmaceutical world than Bristol Myers Squibb (NYSE:BMY) and Gilead Sciences (NASDAQ:GILD). While neither stock was immune to the . . .
Posted on 5/21/20
Better Buy: GlaxoSmithKline vs. Pfizer
GlaxoSmithKline (NYSE:GSK) and Pfizer (NYSE:PFE) have both been in the headlines lately as they lead the way in the race to develop a coronavirus vaccine. While . . .
Posted on 5/4/20
Is Rite Aid Stock a Buy?
If you've been tracking Rite Aid (NYSE:RAD) in recent weeks, you may have noticed an alarming trend. While its competitor Walgreens Boots Alliance (NASDAQ:WBA) remained a . . .
Posted on 4/24/20
Pfizer Targets Summer For COVID-19 Vaccine Human Trials; Potential Treatment Also In The Works
When Pfizer (NYSE:PFE) announced on April 9 that its five-point plan included a promising coronavirus treatment and a potential vaccine candidate in the works, shares soared . . .
Posted on 4/16/20
Should You Scoop Up Bristol Myers Squibb Shares?
Given the extreme volatility the stock market has experienced in the devastating wake of COVID-19, many investors have been setting their sights on dividend stocks as . . .
Posted on 3/2/20
Biogen Could Score a Major Win if Alzheimer's Drug Gets the Green Light
Biogen (NASDAQ:BIIB) had investors more than a little concerned in 2019. The company's efforts to win approval for its highly anticipated Alzheimer's medication, aducanumab, were met . . .
Posted on 2/20/20
Is CVS a Good Buy Right Now?
Investors were waiting with bated breath when CVS Health (NYSE:CVS) released its Q4 earnings on February 12. The company had an excellent Q3, due in no . . .
Posted on 2/12/20
Johnson & Johnson Is Racing Against Time to Develop the First Coronavirus Vaccine
Over the past several weeks, there's nothing that has monopolized the news quite so much as the terrifying and deadly coronavirus. The illness has claimed over . . .
Posted on 1/30/20
Is Merck Still a Strong Buy?
Merck (NYSE:MRK) has long been the apple of investors' eyes, both for its excellent financials and solid dividend payouts. The company enjoyed monumental sales growth in . . .
Posted on 1/24/20
Why Long-Term Investors Should Avoid Teva Stock
Israeli company Teva Pharmaceutical (NYSE:TEVA) has been a leader in the healthcare industry for more than 40 years with offerings ranging from generics, to specialty drugs . . .
Posted on 1/15/20
Why Johnson & Johnson Will Survive its Latest Litigation Wave
Johnson & Johnson (NYSE:JNJ) has long been plagued with lawsuits alleging its talcum products contain the cancer-causing substance asbestos. Unluckily for Johnson & Johnson, these allegations . . .
Posted on 1/15/20
Why Johnson & Johnson Will Survive its Latest Litigation Wave
Johnson & Johnson (NYSE:JNJ) has long been plagued with lawsuits alleging its talcum products contain the cancer-causing substance asbestos. Unluckily for Johnson & Johnson, these allegations . . .
Philadelphia
